ArticleBMC endocrine disorders2025

SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state.

Shu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.